龍資源(01712.HK):Fäboliden採礦許可證案件延期
格隆匯3月18日丨龍資源(01712.HK)公吿,Fäboliden採礦許可證案件的最新進展情況載於2021年中期報吿及日期為2022年3月9日的最新業績公吿。
該公司獲瑞典土地和環境法院吿知,原定於2022年3月14日(星期一)展開的Fboliden採礦許可證案件的主聆訊已吿取消。負責處理Fäboliden案件的法院受到COVID-19疫情影響,法院有幾位職員染病,由於通知倉卒,沒有人能夠替補處理。法院按照應急計劃,提出於以下日期進行新的主聆訊。
第一週,3天;2022年4月11日至4月13日(星期一至星期三);
第二週,2天;2022年4月21日至22日(星期四至星期五)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.